Markets › India › NSE › SUNPHARMA

Sun Pharmaceuticals Industries Ltd

NSE:SUNPHARMAHealthcareNSE:CNX100NSE:CNX200

₹1,743.00−0.90%At closeAt close · Mon 19 Oct · ≈ AED 67.34 · Market cap $44.43B · Next earnings Fri 30 Oct

Ratio	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026	Current · undated	YoY
Gross margin	72.5%	71.9%	74.2%	76.4%	78.0%	55.7%	—	—
Operating margin	45.6%	47.3%	49.9%	50.4%	52.9%	23.2%	23.2%	+0.0 pts
Net margin	8.7%	8.5%	19.3%	19.7%	20.8%	19.6%	19.6%	+0.0 pts
EBITDA margin	24.9%	26.3%	26.5%	26.6%	28.5%	31.4%	—	—
Return on equity	6.2%	6.8%	15.1%	15.0%	15.1%	13.7%	13.7%	−0.1 pts
Return on assets	4.3%	4.7%	10.5%	11.2%	11.9%	10.6%	10.6%	+0.0 pts
Return on capital employed	29.6%	34.8%	36.0%	35.7%	37.6%	15.7%	—	—
Debt / equity	0.1×	0.0×	0.1×	0.1×	0.0×	0.1×	0.1×	−0.4%
Debt / assets	5.7%	1.8%	8.5%	3.8%	2.6%	4.3%	—	—
Interest coverage	108.2×	245.2×	148.9×	102.4×	169.3×	40.0×	—	—
Current ratio	1.9×	2.0×	2.0×	2.6×	2.9×	2.8×	2.8×	+0.0%
Quick ratio	1.3×	1.5×	1.5×	2.0×	2.3×	2.3×	—	—
Cash ratio	0.4×	0.3×	0.2×	0.5×	0.6×	0.5×	0.5×	+0.0%
Asset turnover	0.5×	0.6×	0.5×	0.6×	0.6×	0.5×	—	—
Inventory turnover	1.0×	1.2×	1.1×	1.1×	1.1×	2.3×	—	—
Receivables turnover	3.4×	3.5×	3.8×	4.3×	4.0×	3.8×	—	—
Dividend payout	53.7%	66.0%	29.7%	30.3%	33.1%	34.3%	—	—

Margins, returns, leverage and liquidityUpdated Tue 31 Mar ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.